Results
Differentially Expressed miRNAs List
| miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
|---|---|---|---|---|---|---|---|---|
| hsa-miR-144 | GSE6188 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -1.15 | DOWN | EXP00031 |
| hsa-miR-144 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | -0.48 | DOWN | EXP00042 |
| hsa-miR-144 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | -0.54 | DOWN | EXP00045 |
| hsa-miR-144* | GSE17498 | lymphoma | lymphoma | N/A | high grade vs low grade | 0.75 | UP | EXP00088 |
| hsa-miR-144 | GSE22058 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | -0.24 | DOWN | EXP00100 |
| hsa-miR-144 | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | 2.07 | UP | EXP00102 |
| hsa-miR-144 | GSE6857 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.88 | UP | EXP00081 |
| hsa-miR-144 | GSE15008 | lung cancer | lung cancer | N/A | cancer vs normal | -1.99 | DOWN | EXP00070 |
| hsa-miR-144 | GSE2564 | prostate cancer | prostate cancer | N/A | cancer vs normal | -1.69 | DOWN | EXP00020 |
| hsa-miR-144 | GSE2564 | lung cancer | lung cancer | N/A | cancer vs normal | -1.98 | DOWN | EXP00022 |
| hsa-miR-144 | GSE2564 | leukemia | leukemia | N/A | subtype1 vs substype2 | 2.15 | UP | EXP00027 |
| hsa-miR-144 | GSE4589 | breast cancer | breast cancer | N/A | cancer vs normal | 2.95 | UP | EXP00029 |
| hsa-miR-144 | GSE5244 | uterus cancer | uterus cancer | N/A | cancer vs normal | -1.09 | DOWN | EXP00030 |
| hsa-miR-144 | GSE2399 | lymphoma | lymphoma | Karpas-1718 | cancer vs normal | -1.72 | DOWN | EXP00006 |
| hsa-miR-144 | GSE2399 | lymphoma | lymphoma | OCI-Ly4 | cancer vs normal | -1.75 | DOWN | EXP00001 |